A case series of cutaneous COVID-19 vaccine reactions at Loma Linda University Department of Dermatology
G. Alden Holmes, Mansee Desai, Brittanya Limone, Justin Love, Melanie Tawfik, Lulu Wong, Betsy Furukawa
Abstract
To date, the United States Food and Drug Administration has issued emergency use authorization for 3 vaccines for the prevention of COVID-19: Pfizer-BioNTech's COVID-19 vaccine, Moderna's COVID-19 vaccine, and Janssen's COVID-19 vaccine.1,2
Topics & Concepts
Coronavirus disease 2019 (COVID-19)MedicineFood and drug administration2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DermatologyAuthorizationEmergency departmentVirologyMedical emergencyPathologyOutbreakInfectious disease (medical specialty)DiseasePsychiatryComputer scienceComputer securityDermatological and COVID-19 studiesAutoimmune Bullous Skin DiseasesDrug-Induced Adverse Reactions